D2-40 in breast cancer: should we detect more vascular emboli?

Isabelle de Mascarel,Gaëtan MacGrogan,Marc Debled,Ghislaine Sierankowski,Véronique Brouste,Simone Mathoulin-Pélissier,Louis Mauriac

DOI: https://doi.org/10.1038/modpathol.2008.151

IF: 8.209

2008-09-26

Modern Pathology

Abstract:Peritumoral emboli assessed on hematoxylin–eosin-stained slides are taken into account for treatment of patients with operable breast cancer. We assessed whether immunostaining with D2-40 improves the prognostic significance of emboli in a group of tumors with a large immunohistochemical sampling and a long-term follow-up. Topography, number, and extension of hematoxylin–eosin and D2-40 emboli were compared in 94 node-negative breast cancers (median number of immunostained slides per tumor: 3). Metastatasis-free survival of patients with or without hematoxylin–eosin and/or D2-40 emboli were evaluated (median follow-up of 178 months). Hematoxylin–eosin emboli were detected in 14 (15%) tumors and were located at distance from the tumor. D2-40 emboli were detected in 39 (41%) tumors and was often multiple (n=30), extensive (n=23), located within (n=13), close to (n=10) or at distance from the tumor (n=16). The 12 distant hematoxylin–eosin and D2-40 emboli were located in the same vessels (seven missed at the first hematoxylin–eosin examination and secondarily diagnosed by D2-40 staining). A difference in metastasis-free survival was found only between patients with no D2-40 emboli and those with distant D2-40 emboli (P=0.02). D2-40 emboli located within or close to the tumor had no prognostic value. Comparing the metastasis-free survival of patients with or without hematoxylin–eosin emboli, the prognostically unfavorable significance of hematoxylin–eosin emboli was improved when taking into account the seven patients with missed emboli at the first examination and secondarily diagnosed by D2-40 staining (P=0.006 vs 0.003). To conclude, D2-40 increases the diagnostic sensitivity of emboli in breast carcinoma and the high incidence of D2-40 emboli might be related to the number of immunostained slides per case. Nevertheless, only distant D2-40+ emboli had a prognostic impact. In practice, D2-40 might be useful to detect missed hematoxylin–eosin emboli especially in cases without any other prognostically unfavorable criterion.

pathology